Behrens, Ronald H <br/><br/>
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.  [electronic resource] 

 -  The Lancet. Infectious diseases  Mar 2014 
 - 197-204 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(13)70297-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adolescent<br/>Adult<br/>Bacterial Toxins--immunology<br/>Developing Countries<br/>Diarrhea--microbiology<br/>Double-Blind Method<br/>Drug Delivery Systems<br/>Enterotoxins--immunology<br/>Escherichia coli--immunology<br/>Escherichia coli Proteins--immunology<br/>Escherichia coli Vaccines--administration & dosage<br/>Europe<br/>Female<br/>Guatemala<br/>Humans<br/>Immunization--methods<br/>Male<br/>Mexico<br/>Middle Aged<br/>Travel<br/>Young Adult